|
CKAP2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.232600E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.062000E-01 |
| Normal-vs-Stage2 |
3.303200E-01 |
| Normal-vs-Stage3 |
5.978200E-01 |
| Normal-vs-Stage4 |
9.287200E-01 |
| Stage1-vs-Stage2 |
1.977780E-01 |
| Stage1-vs-Stage3 |
3.625000E-01 |
| Stage1-vs-Stage4 |
8.204800E-01 |
| Stage2-vs-Stage3 |
6.006800E-01 |
| Stage2-vs-Stage4 |
4.395400E-01 |
| Stage3-vs-Stage4 |
6.992400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.250600E-01 |
| Normal-vs-AfricanAmerican |
2.749600E-01 |
| Normal-vs-Asian |
6.372800E-01 |
| Caucasian-vs-AfricanAmerican |
2.461800E-01 |
| Caucasian-vs-Asian |
5.259200E-01 |
| AfricanAmerican-vs-Asian |
1.591610E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.998800E-01 |
| Normal-vs-Female |
6.846200E-01 |
| Male-vs-Female |
3.412400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.398200E-01 |
| Normal-vs-Age(41-60Yrs) |
2.429000E-01 |
| Normal-vs-Age(61-80Yrs) |
9.216000E-01 |
| Normal-vs-Age(81-100Yrs) |
6.180800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.681800E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.116400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.379200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.731600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.817400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.136000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.163000E-01 |
| Classical-VS-Follicular |
4.384000E-04 |
| Classical-VS-Other |
4.327600E-01 |
| Classical-VS-Normal |
5.704000E-01 |
| Tall-VS-Follicular |
8.854100E-02 |
| Tall-VS-Other |
6.261200E-01 |
| Tall-VS-Normal |
9.468200E-01 |
| Follicular-VS-Other |
6.858400E-01 |
| Follicular-VS-Normal |
3.801600E-02 |
| Other-VS-Normal |
5.633200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.109600E-01 |
| Normal-vs-N1 |
4.135800E-01 |
| N0-vs-N1 |
6.454600E-01 |
|
|
